The Nutraceutical Market: OTFs are ushering in a new era of adherence
Globally, the approach towards health and disease management is changing towards ‘preventative’ than ‘curative’. Millennials of today work sedentary office jobs and have poor dietary habits including increased consumption of junk and packaged foods, alcohol and carbonated beverages, skipping meals, trying fad diets and more. This demographic is increasingly adopting nutritional supplementation as a way to counteract their chaotic lifestyle. The booming Nutraceutical market is evidence of this paradigm shift in health management.
Need for Nutraceuticals: Supplementation against lifestyle diseases
Globally lifestyle diseases and noncommunicable diseases are at an all-time high with 70% of deaths worldwide now being attributed to them. To fight this growing disease burden, people are looking at Nutraceuticals as a panacea. Nutraceuticals, consumed on a regular basis over a long term were found to have a statistically significant preventative effect against lifestyle and chronic diseases such as Hypertension, Osteoporosis, Arthritis, and Macular degeneration.
Lack of adherence: A bottleneck for the sector
Driven by the health-conscious customer annual sales of the nutraceutical market reached approximately $150 billion in 2015, one fifth the size of the pharma industry. However, over the last two years, the growth rate of the industry has slowed to around 7% due to a saturated market and dying innovation in the sector.
A major bottleneck hampering the segment is the need for the behavioral change of the customer to sustain a supplementation regimen. Since the benefits of supplementation can only be observed in the long term, it is essential that administering them should be highly convenient for the customer to improve adherence. Also, the need to take multiple supplements for different vitamins, minerals, and micronutrients make portability of these drugs essential, which is currently missing in their conventional form as pills and capsules.
Oral Thin Films: Driving the next wave of growth
The entry of Oral Thin Films in the Nutraceutical market can help solve the adherence problem faced by the nutraceutical sector by making it easier for the customer to ingest them. Oral Films which dissolve when coming into contact with saliva are a much more convenient alternative to conventional drug delivery systems as they don’t require water or other paraphernalia such as glasses, spoons etc to be administered.
They are also lower in the number of excipients, reducing load of excipients on the body by about 70% as compared to traditional oral medication. This leads to a reduction in the size of doses, likelihood of overdoses and side effects. The adoption of thin films as a drug delivery mechanism is making nutraceuticals safe, portable and easier to administer.
The improved taste-masking technology of oral thin films is also a major plus as it helps mask the bitterness of active ingredients allowing nutraceutical manufacturers to create different flavors of the same product to bring in variety and help make it more palatable and marketable to end customers.
Looking to leverage new drug delivery systems for your nutraceutical product?
Zimlabs is one of the leading innovators in the Oral Thin Films space with their proprietary Thinoral® technology. They have 24 Drug Controller General of India (DGCI) approvals and enjoys widespread adoption in the Nutraceutical and Pharma industry. Drugs manufactured on the Thinoral® platform are exported to 25+ countries across the globe.
Get the Thinoral® edge – Contact our manufacturing team today.